GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Cash Paid for Insurance Activities

BerGenBio ASA (OSL:BGBIO) Cash Paid for Insurance Activities


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Cash Paid for Insurance Activities?

Cash Paid for Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


BerGenBio ASA Business Description

Industry
Traded in Other Exchanges
Address
Nygardsgaten 114, Bergen, NOR, 5008
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.